Revance Therapeutics RVNC
$ 3.75
-2.47%
Quarterly report 2024-Q3
added 11-07-2024
Revance Therapeutics Total Current Liabilities 2011-2024 | RVNC
Annual Total Current Liabilities Revance Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
89.2 M | 75.7 M | 67.3 M | 61 M | 41 M | 32 M | 20.9 M | 19.6 M | 12 M | 10.2 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
89.2 M | 10.2 M | 42.9 M |